
Integrated Diagnostics Holdings PLC
LSE:IDHC

Wall Street
Price Targets
IDHC Price Targets Summary
Integrated Diagnostics Holdings PLC
According to Wall Street analysts, the average 1-year price target for
IDHC
is 0.699 USD
with a low forecast of 0.455 USD and a high forecast of 0.966 USD.
Price Targets
Revenue
Forecast
Revenue Estimate
Integrated Diagnostics Holdings PLC
For the last 11 years the
compound annual growth rate for
Integrated Diagnostics Holdings PLC's revenue is
21%.
The projected
CAGR
for the next 3 years is
20%.
Operating Income
Forecast
Operating Income Estimate
Integrated Diagnostics Holdings PLC
For the last 11 years the
compound annual growth rate for
Integrated Diagnostics Holdings PLC's operating income is
22%.
The projected
CAGR
for the next 3 years is
32%.
Net Income
Forecast
Net Income Estimate
Integrated Diagnostics Holdings PLC
For the last 11 years the
compound annual growth rate for
Integrated Diagnostics Holdings PLC's net income is
30%.
The projected
CAGR
for the next 2 years is
13%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IDHC's stock price target?
Price Target
0.699
USD
According to Wall Street analysts, the average 1-year price target for
IDHC
is 0.699 USD
with a low forecast of 0.455 USD and a high forecast of 0.966 USD.
What is Integrated Diagnostics Holdings PLC's Revenue forecast?
Projected CAGR
20%
For the last 11 years the
compound annual growth rate for
Integrated Diagnostics Holdings PLC's revenue is
21%.
The projected
CAGR
for the next 3 years is
20%.
What is Integrated Diagnostics Holdings PLC's Operating Income forecast?
Projected CAGR
32%
For the last 11 years the
compound annual growth rate for
Integrated Diagnostics Holdings PLC's operating income is
22%.
The projected
CAGR
for the next 3 years is
32%.
What is Integrated Diagnostics Holdings PLC's Net Income forecast?
Projected CAGR
13%
For the last 11 years the
compound annual growth rate for
Integrated Diagnostics Holdings PLC's net income is
30%.
The projected
CAGR
for the next 2 years is
13%.